🚨 INJ vs SUI: Big ambitions, but do the numbers tell a different story?
Injective is moving toward institutional finance, tokenized assets and ETF products. Sounds bullish, right? 👀
But there’s one uncomfortable question: where is the real liquidity?
💧 Injective TVL: ~$14M
💧 Sui TVL: ~$500M
That’s a gap of roughly 35x.
And here’s the catch: a huge trading volume doesn’t automatically mean deep liquidity, while an ETF filing doesn’t guarantee approval or institutional inflows.
Sui has built a considerably larger DeFi ecosystem. Injective still has a lot to prove when it comes to turning its ambitions into real on-chain adoption.
Maybe the market is pricing in the future — but shouldn’t the fundamentals catch up eventually?
What do you think: is $INJ undervalued, or is $SUI building the stronger foundation? 👇
#injective #INJ #SUI #crypto #DeFi
Injective is moving toward institutional finance, tokenized assets and ETF products. Sounds bullish, right? 👀
But there’s one uncomfortable question: where is the real liquidity?
💧 Injective TVL: ~$14M
💧 Sui TVL: ~$500M
That’s a gap of roughly 35x.
And here’s the catch: a huge trading volume doesn’t automatically mean deep liquidity, while an ETF filing doesn’t guarantee approval or institutional inflows.
Sui has built a considerably larger DeFi ecosystem. Injective still has a lot to prove when it comes to turning its ambitions into real on-chain adoption.
Maybe the market is pricing in the future — but shouldn’t the fundamentals catch up eventually?
What do you think: is $INJ undervalued, or is $SUI building the stronger foundation? 👇
#injective #INJ #SUI #crypto #DeFi